Choice of cardioplegia influences metabolomics of human cardiac tissue
Proceedings of the National Academy of Sciences · 19.05.2026 · 123 (20)
DOI: 10.1073/pnas.2602039123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 07.05.2026. Verfasst von Sho Tanosaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104. Hauptthemen laut MEDLINE: Metabolomics, Myocardium, Heart Arrest, Induced, Cardioplegic Solutions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Heart Association (AHA), HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Takeda Science Foundation (TSF).
Abstract (Originalsprache)
Cardioplegia is often used prior to acquisition of human cardiac tissue to minimize warm ischemia time, which can severely confound studies of cardiac metabolism. However, there are several choices of cardioplegia solutions, and whether these solutions differentially impact tissue metabolism or metabolomic studies is not known. Here, we perform untargeted metabolomics, using both liquid chromatography–mass spectrometry and gas chromatography–mass spectrometry, on a large cohort of hearts transplanted for cardiomyopathy or from gift-of-life donors, and who have received different cardioplegia solutions. We show that different cardioplegia solutions distinctly impact cardiac metabolism and tissue metabolomic studies. Notably, these differences are mild relative to those seen comparing failing to nonfailing hearts, and identification of cardioplegia components in mass spectra should enable rigorous interpretation of changes between conditions. These data demonstrate how cardioplegia solutions may influence cardiac metabolism in human heart samples and underscore the need to report specific details of cardioplegia solution use in studies of human cardiac metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
- Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
- Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of California, Los Angeles, CA 90095.
- Department of Biochemistry, University of Utah, Salt Lake City, UT 84112.
- Metabolomics Core Research Facility, University of Utah, Salt Lake City, UT 84112.
ORCID-Profile: Kenneth Margulies, E Dale Abel
Förderung
- American Heart Association (AHA)
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- Takeda Science Foundation (TSF)
- NHLBI NIH HHS
Zitieren
APA
Tanosaki, S., Zhang, Y., Bedi, K., Margulies, K., Cox, J. E., Arany, Z., & Abel, E. D. (2026). Choice of cardioplegia influences metabolomics of human cardiac tissue. Proceedings of the National Academy of Sciences, 123(20). https://doi.org/10.1073/pnas.2602039123
Vancouver
Tanosaki S, Zhang Y, Bedi K, Margulies K, Cox JE, Arany Z, et al. Choice of cardioplegia influences metabolomics of human cardiac tissue. Proceedings of the National Academy of Sciences. 2026;123(20). doi:10.1073/pnas.2602039123
BibTeX
@article{Tanosaki2026,
author = {Tanosaki, Sho and Zhang, Yuan and Bedi, Kenneth and Margulies, Kenneth and Cox, James E and Arany, Zoltan and Abel, E Dale},
title = {Choice of cardioplegia influences metabolomics of human cardiac tissue},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {20},
doi = {10.1073/pnas.2602039123}
}
EUVIMED